TP53 and mantle cell lymphoma: Six hundred eighty-four patients (MCL Younger n = 390, MCL Elderly n = 294) out of 1183 registered study patients with MCL from the training cohort had evaluable data either for Ki-67 or p53 (Supplemental Fig. 1).